학술논문

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy.
Document Type
Article
Source
CNS Neuroscience & Therapeutics. Feb2023, Vol. 29 Issue 2, p538-543. 6p.
Subject
*CEREBRAL atrophy
*SARS-CoV-2
*MULTIPLE sclerosis
*GRAY matter (Nerve tissue)
*MAGNETIC resonance imaging
Language
ISSN
1755-5930
Abstract
Introduction: Data on structural brain changes after infection with SARS‐CoV‐2 is sparse. We postulate multiple sclerosis as a model to study the effects of SARS‐CoV‐2 on brain atrophy due to the unique availability of longitudinal imaging data in this patient group, enabling assessment of intraindividual brain atrophy rates. Methods: Global and regional cortical gray matter volumes were derived from structural MRIs using FreeSurfer. A linear model was fitted to the measures of the matching pre‐SARS‐CoV‐2 images with age as an explanatory variable. The residuals were used to determine whether the post‐SARS‐CoV‐2 volumes differed significantly from the baseline. Results: Fourteen RRMS patients with a total of 113 longitudinal magnetic resonance images were retrospectively analyzed. We found no acceleration of brain atrophy after infection with SARS‐CoV‐2 for global gray matter volume (p = 0.17). However, on the regional level, parahippocampal gyri showed a tendency toward volume reduction (p = 0.0076), suggesting accelerated atrophy during or after infection. Conclusions: Our results illustrate the opportunity of using longitudinal MRIs from existing MS registries to study brain changes associated with SARS‐CoV‐2 infections. We would like to address the global MS community with a call for action to use the available cohorts, reproduce the proposed analysis, and pool the results. [ABSTRACT FROM AUTHOR]